Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Specialty Active Pharmaceutical Ingredients market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Specialty Active Pharmaceutical Ingredients market. Detailed analysis of key players, along with key growth strategies adopted by Specialty Active Pharmaceutical Ingredients industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Almac
AmbioPharm
Cambrex
ST Pharm
Johnson Matthey
Avecia
PolyPeptide
Biospring
By Type:
Steroidal API
Peptide API
Carbohydrate API
Small Molecule API
High Potency AP
By End-User:
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Rheumatology
Diabetes
Oncology
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Specialty Active Pharmaceutical Ingredients Market
-
1.3 Market Segment by Type
-
1.3.1 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Steroidal API from 2016 to 2027
-
1.3.2 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Peptide API from 2016 to 2027
-
1.3.3 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Carbohydrate API from 2016 to 2027
-
1.3.4 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Small Molecule API from 2016 to 2027
-
1.3.5 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of High Potency AP from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of CNS from 2016 to 2027
-
1.4.2 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
1.4.3 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Genitourinary/Hormonal Drugs from 2016 to 2027
-
1.4.4 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Rheumatology from 2016 to 2027
-
1.4.5 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Diabetes from 2016 to 2027
-
1.4.6 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.7 USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Specialty Active Pharmaceutical Ingredients Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Specialty Active Pharmaceutical Ingredients by Major Types
-
3.4.1 Market Size and Growth Rate of Steroidal API
-
3.4.2 Market Size and Growth Rate of Peptide API
-
3.4.3 Market Size and Growth Rate of Carbohydrate API
-
3.4.4 Market Size and Growth Rate of Small Molecule API
-
3.4.5 Market Size and Growth Rate of High Potency AP
4 Segmentation of Specialty Active Pharmaceutical Ingredients Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Specialty Active Pharmaceutical Ingredients by Major End-Users
-
4.4.1 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in CNS
-
4.4.2 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in Cardiovascular
-
4.4.3 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in Genitourinary/Hormonal Drugs
-
4.4.4 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in Rheumatology
-
4.4.5 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in Diabetes
-
4.4.6 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in Oncology
-
4.4.7 Market Size and Growth Rate of Specialty Active Pharmaceutical Ingredients in Others
5 Market Analysis by Regions
-
5.1 USA Specialty Active Pharmaceutical Ingredients Production Analysis by Regions
-
5.2 USA Specialty Active Pharmaceutical Ingredients Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Specialty Active Pharmaceutical Ingredients Landscape Analysis
-
6.1 West USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major Types
-
6.2 West USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major End-Users
7 South USA Specialty Active Pharmaceutical Ingredients Landscape Analysis
-
7.1 South USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major Types
-
7.2 South USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major End-Users
8 Middle West USA Specialty Active Pharmaceutical Ingredients Landscape Analysis
-
8.1 Middle West USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major Types
-
8.2 Middle West USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major End-Users
9 Northeast USA Specialty Active Pharmaceutical Ingredients Landscape Analysis
-
9.1 Northeast USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major Types
-
9.2 Northeast USA Specialty Active Pharmaceutical Ingredients Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Almac
-
10.1.1 Almac Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 AmbioPharm
-
10.2.1 AmbioPharm Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Cambrex
-
10.3.1 Cambrex Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 ST Pharm
-
10.4.1 ST Pharm Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Johnson Matthey
-
10.5.1 Johnson Matthey Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Avecia
-
10.6.1 Avecia Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 PolyPeptide
-
10.7.1 PolyPeptide Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Biospring
-
10.8.1 Biospring Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Steroidal API from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Peptide API from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Carbohydrate API from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Small Molecule API from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of High Potency AP from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of CNS from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Genitourinary/Hormonal Drugs from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Rheumatology from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Diabetes from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure USA Specialty Active Pharmaceutical Ingredients Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Specialty Active Pharmaceutical Ingredients Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Specialty Active Pharmaceutical Ingredients
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Specialty Active Pharmaceutical Ingredients by Different Types from 2016 to 2027
-
Table Consumption Share of Specialty Active Pharmaceutical Ingredients by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Steroidal API
-
Figure Market Size and Growth Rate of Peptide API
-
Figure Market Size and Growth Rate of Carbohydrate API
-
Figure Market Size and Growth Rate of Small Molecule API
-
Figure Market Size and Growth Rate of High Potency AP
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Specialty Active Pharmaceutical Ingredients by Different End-Users from 2016 to 2027
-
Table Consumption Share of Specialty Active Pharmaceutical Ingredients by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of CNS
-
Figure Market Size and Growth Rate of Cardiovascular
-
Figure Market Size and Growth Rate of Genitourinary/Hormonal Drugs
-
Figure Market Size and Growth Rate of Rheumatology
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Others
-
Table USA Specialty Active Pharmaceutical Ingredients Production by Regions
-
Table USA Specialty Active Pharmaceutical Ingredients Production Share by Regions
-
Figure USA Specialty Active Pharmaceutical Ingredients Production Share by Regions in 2016
-
Figure USA Specialty Active Pharmaceutical Ingredients Production Share by Regions in 2021
-
Figure USA Specialty Active Pharmaceutical Ingredients Production Share by Regions in 2027
-
Table USA Specialty Active Pharmaceutical Ingredients Consumption by Regions
-
Table USA Specialty Active Pharmaceutical Ingredients Consumption Share by Regions
-
Figure USA Specialty Active Pharmaceutical Ingredients Consumption Share by Regions in 2016
-
Figure USA Specialty Active Pharmaceutical Ingredients Consumption Share by Regions in 2021
-
Figure USA Specialty Active Pharmaceutical Ingredients Consumption Share by Regions in 2027
-
Table West USA Specialty Active Pharmaceutical Ingredients Consumption by Types from 2016 to 2027
-
Table West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types from 2016 to 2027
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2016
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2021
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2027
-
Table West USA Specialty Active Pharmaceutical Ingredients Consumption by End-Users from 2016 to 2027
-
Table West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2016
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2021
-
Figure West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2027
-
Table South USA Specialty Active Pharmaceutical Ingredients Consumption by Types from 2016 to 2027
-
Table South USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types from 2016 to 2027
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2016
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2021
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2027
-
Table South USA Specialty Active Pharmaceutical Ingredients Consumption by End-Users from 2016 to 2027
-
Table South USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2016
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2021
-
Figure South USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2027
-
Table Middle West USA Specialty Active Pharmaceutical Ingredients Consumption by Types from 2016 to 2027
-
Table Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2016
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2021
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2027
-
Table Middle West USA Specialty Active Pharmaceutical Ingredients Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2016
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2021
-
Figure Middle West USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2027
-
Table Northeast USA Specialty Active Pharmaceutical Ingredients Consumption by Types from 2016 to 2027
-
Table Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2016
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2021
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by Types in 2027
-
Table Northeast USA Specialty Active Pharmaceutical Ingredients Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2016
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2021
-
Figure Northeast USA Specialty Active Pharmaceutical Ingredients Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Almac
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Almac
-
Figure Sales and Growth Rate Analysis of Almac
-
Figure Revenue and Market Share Analysis of Almac
-
Table Product and Service Introduction of Almac
-
Table Company Profile and Development Status of AmbioPharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AmbioPharm
-
Figure Sales and Growth Rate Analysis of AmbioPharm
-
Figure Revenue and Market Share Analysis of AmbioPharm
-
Table Product and Service Introduction of AmbioPharm
-
Table Company Profile and Development Status of Cambrex
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cambrex
-
Figure Sales and Growth Rate Analysis of Cambrex
-
Figure Revenue and Market Share Analysis of Cambrex
-
Table Product and Service Introduction of Cambrex
-
Table Company Profile and Development Status of ST Pharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ST Pharm
-
Figure Sales and Growth Rate Analysis of ST Pharm
-
Figure Revenue and Market Share Analysis of ST Pharm
-
Table Product and Service Introduction of ST Pharm
-
Table Company Profile and Development Status of Johnson Matthey
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson Matthey
-
Figure Sales and Growth Rate Analysis of Johnson Matthey
-
Figure Revenue and Market Share Analysis of Johnson Matthey
-
Table Product and Service Introduction of Johnson Matthey
-
Table Company Profile and Development Status of Avecia
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avecia
-
Figure Sales and Growth Rate Analysis of Avecia
-
Figure Revenue and Market Share Analysis of Avecia
-
Table Product and Service Introduction of Avecia
-
Table Company Profile and Development Status of PolyPeptide
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PolyPeptide
-
Figure Sales and Growth Rate Analysis of PolyPeptide
-
Figure Revenue and Market Share Analysis of PolyPeptide
-
Table Product and Service Introduction of PolyPeptide
-
Table Company Profile and Development Status of Biospring
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biospring
-
Figure Sales and Growth Rate Analysis of Biospring
-
Figure Revenue and Market Share Analysis of Biospring
-
Table Product and Service Introduction of Biospring
-
